Alcohol use and alcohol use disorders in Mexico

摘要

Funding for this study came from the Ramon de la Fuente National Institute of Psychiatry (grant 4280) and the National Council on Science and Technology of Mexico (grant G30544-H), with supplemental support from the Pan American Health Organization and the Pfizer Foundation, Mexico. The Mexican National Comorbidity Survey was carried out in conjunction with the World Health Organization's World Mental Health (WMH) Survey Initiative. We thank the WMH staff for assistance with instrumentation, fieldwork and data analysis. These activities were supported the United States National Institute of Mental Health (grant R0IMH070884), the John D. and Catherine T. Macarthur Foundation, the Pfizer Foundation, the United States Public Health Service (grants R13-MH066849, R01-MH069864 and R01 DA016558), the Fogarty International Center (FIRCA grant R01TW00648I), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, GlaxoSmithKline and Bristol-Myers Squibb.